TB Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

TB Group şirketinin toplam hissedar öz sermayesi ¥669.0M ve toplam borcu ¥371.0M olup, bu da borç-öz sermaye oranını 55.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥1.4B ve ¥746.0M dir.

Anahtar bilgiler

55.5%

Borç/özkaynak oranı

JP¥371.00m

Borç

Faiz karşılama oranı	n/a
Nakit	JP¥216.00m
Eşitlik	JP¥669.00m
Toplam yükümlülükler	JP¥746.00m
Toplam varlıklar	JP¥1.42b

Son finansal sağlık güncellemeleri

Is TB Group (TSE:6775) Using Too Much Debt?

Aug 02

Is TB Group (TSE:6775) Weighed On By Its Debt Load?

Mar 16

Recent updates

TB Group Inc.'s (TSE:6775) 40% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Aug 06

Is TB Group (TSE:6775) Using Too Much Debt?

Aug 02

Revenues Not Telling The Story For TB Group Inc. (TSE:6775) After Shares Rise 31%

Mar 27

Is TB Group (TSE:6775) Weighed On By Its Debt Load?

Mar 16

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 6775 'nin kısa vadeli varlıkları ( ¥1.0B ) kısa vadeli yükümlülüklerini ( ¥406.0M ) aşıyor.

Uzun Vadeli Yükümlülükler: 6775 şirketinin kısa vadeli varlıkları ( ¥1.0B ) uzun vadeli yükümlülüklerini ( ¥340.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 6775 'nin net borç/öz sermaye oranı ( 23.2% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 6775 şirketinin borç/öz sermaye oranı son 5 yılda 11% seviyesinden 55.5% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: 6775 şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: 6775 un, serbest nakit akışı her yıl % 12.4 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

TB Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is TB Group (TSE:6775) Using Too Much Debt?

Is TB Group (TSE:6775) Weighed On By Its Debt Load?

Recent updates

New major risk - Financial position

Second quarter 2025 earnings released: JP¥4.31 loss per share (vs JP¥1.39 loss in 2Q 2024)

TB Group Inc. to Report Q2, 2025 Results on Nov 08, 2024

First quarter 2025 earnings released: JP¥5.04 loss per share (vs JP¥5.59 loss in 1Q 2024)

TB Group Inc.'s (TSE:6775) 40% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

New major risk - Market cap size

Is TB Group (TSE:6775) Using Too Much Debt?

TB Group Inc. to Report Q1, 2025 Results on Aug 09, 2024

Full year 2024 earnings released: JP¥17.86 loss per share (vs JP¥22.92 loss in FY 2023)

TB Group Inc., Annual General Meeting, Jun 27, 2024

New major risk - Share price stability

TB Group Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Revenues Not Telling The Story For TB Group Inc. (TSE:6775) After Shares Rise 31%

Is TB Group (TSE:6775) Weighed On By Its Debt Load?

Third quarter 2024 earnings released: JP¥4.90 loss per share (vs JP¥3.20 loss in 3Q 2023)

TB Group Inc. to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: JP¥1.39 loss per share (vs JP¥9.02 loss in 2Q 2023)

TB Group Inc. to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings released: JP¥5.59 loss per share (vs JP¥4.66 loss in 1Q 2023)

TB Group Inc. to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings released: JP¥22.92 loss per share (vs JP¥21.85 loss in FY 2022)

Third quarter 2023 earnings released: JP¥3.20 loss per share (vs JP¥4.37 loss in 3Q 2022)

TB Group Inc. announced that it has received ¥302.748252 million in funding from HospitalNet Inc., Progressive Intelligence Fund, L.P., Modern Path LLC

TB Group Inc. to Report Q3, 2023 Results on Feb 10, 2023

Second quarter 2023 earnings released: JP¥9.02 loss per share (vs JP¥1.44 loss in 2Q 2022)

No independent directors

Second quarter 2023 earnings released: JP¥9.02 loss per share (vs JP¥1.44 loss in 2Q 2022)

TB Group Inc. to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: JP¥4.66 loss per share (vs JP¥6.40 loss in 1Q 2022)

TB Group Inc. to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings released: JP¥21.85 loss per share (vs JP¥46.74 loss in FY 2021)

TB Group Inc., Annual General Meeting, Jun 29, 2022

No independent directors

TB Group Inc. to Report Fiscal Year 2022 Results on May 12, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: JP¥1.44 loss per share (vs JP¥9.92 loss in 2Q 2021)

TB Group Inc. announced that it has received ¥199.9998 million in funding from HospitalNet Inc.

First quarter 2022 earnings released: JP¥6.40 loss per share (vs JP¥12.06 loss in 1Q 2021)

Full year 2021 earnings released: JP¥46.74 loss per share (vs JP¥30.23 loss in FY 2020)

Third quarter 2021 earnings released: JP¥8.00 loss per share (vs JP¥9.82 loss in 3Q 2020)

TB Group Inc. to Report Q3, 2021 Results on Feb 12, 2021

New 90-day low: JP¥170

TB Group Inc. to Report Q1, 2021 Results on Aug 12, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin